Biorem Inc Stock Today
| BRM Stock | CAD 1.96 0.01 0.51% |
Performance15 of 100
| Odds Of DistressLess than 1
|
BioRem is selling for under 1.96 as of the 19th of April 2024; that is -0.51 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.86. BioRem has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Equity ratings for BioRem Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Capital Goods | Category Industrials |
BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. The company has 15.7 M outstanding shares of which 279 shares are currently shorted by private and institutional investors with about 0.02 days to cover all short positions. More on BioRem Inc
Moving against BioRem Stock
| 0.47 | TD | Toronto Dominion Bank | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BioRem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioRem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioRem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | PEng MBA | ||||
| Business Concentration | Industrial Machinery & Supplies & Components, Pollution & Treatment Controls, Industrials, Industrials, Machinery, Pollution & Treatment Controls, Industrials (View all Sectors) | ||||
BioRem's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to BioRem's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BioRem's financial leverage. It provides some insight into what part of BioRem's total assets is financed by creditors.
| |||||
BioRem Inc (BRM) is traded on TSX Venture Exchange in Canada and employs 10 people. BioRem is listed under Industrial Machinery & Supplies & Components category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 30.92 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioRem's market, we take the total number of its shares issued and multiply it by BioRem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioRem Inc classifies itself under Machinery sector and is part of Industrials industry. The entity has 15.7 M outstanding shares of which 279 shares are currently shorted by private and institutional investors with about 0.02 days to cover all short positions.
BioRem Inc has accumulated about 5.75 M in cash with 490.03 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check BioRem Probability Of Bankruptcy
Ownership AllocationBioRem Inc retains a total of 15.7 Million outstanding shares. Almost 98.0 percent of BioRem outstanding shares are held by general public with 1.93 (percent) owned by insiders and only 0.0 % by other corporate entities. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check BioRem Ownership Details
BioRem Stock Price Odds Analysis
Depending on a normal probability distribution, the odds of BioRem jumping above the current price in 90 days from now is near 1%. The BioRem Inc probability density function shows the probability of BioRem stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon BioRem Inc has a beta of -0.5218 suggesting as returns on the benchmark increase, returns on holding BioRem are expected to decrease at a much lower rate. During a bear market, however, BioRem Inc is likely to outperform the market. Moreover, bioRem Inc has an alpha of 1.1449, implying that it can generate a 1.14 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of BioRem to move above the current price in 90 days from now is near 1 (This BioRem Inc probability density function shows the probability of BioRem Stock to fall within a particular range of prices over 90 days) .
BioRem Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. BioRem market risk premium is the additional return an investor will receive from holding BioRem long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioRem. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although BioRem's alpha and beta are two of the key measurements used to evaluate BioRem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.85 | |||
| Semi Deviation | 1.17 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.31 |
BioRem Stock Against Markets
Picking the right benchmark for BioRem stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioRem stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioRem is critical whether you are bullish or bearish towards BioRem Inc at a given time. Please also check how BioRem's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioRem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
BioRem Corporate Executives
Elected by the shareholders, the BioRem's board of directors comprises two types of representatives: BioRem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRem. The board's role is to monitor BioRem's management team and ensure that shareholders' interests are well served. BioRem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Newman | CFO, Secretary | Profile |
How to buy BioRem Stock?
Before investing in BioRem, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in BioRem. To buy BioRem stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of BioRem. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase BioRem stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located BioRem Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased BioRem Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as BioRem Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in BioRem Inc?
The danger of trading BioRem Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of BioRem is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than BioRem. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile BioRem Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioRem Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for BioRem Stock analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |